These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

913 related articles for article (PubMed ID: 34750810)

  • 21. Guillain-Barré syndrome and COVID-19 vaccines: focus on adenoviral vectors.
    Rzymski P
    Front Immunol; 2023; 14():1183258. PubMed ID: 37180147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The First Guillain-Barr? Syndrome After SARS-CoV-2 Vaccination in Taiwan.
    Su SC; Lyu RK; Chang CW; Tseng WJ
    Acta Neurol Taiwan; 2022 Jan; 31(1)():46-51. PubMed ID: 34988954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurological autoimmune diseases following vaccinations against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A follow-up study.
    Doubrovinskaia S; Mooshage CM; Seliger C; Lorenz HM; Nagel S; Lehnert P; Purrucker J; Wildemann B; Bendszus M; Wick W; Schönenberger S; Kaulen LD
    Eur J Neurol; 2023 Feb; 30(2):463-473. PubMed ID: 36259114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurological Complications Following COVID-19 Vaccination.
    Chatterjee A; Chakravarty A
    Curr Neurol Neurosci Rep; 2023 Jan; 23(1):1-14. PubMed ID: 36445631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-SARS-CoV-2 vaccination venous sinus thrombosis: a literature review of 308 cases.
    Finsterer J; Zarrouk S
    Egypt J Neurol Psychiatr Neurosurg; 2021; 57(1):179. PubMed ID: 34955632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global uncertainty in the diagnosis of neurological complications of SARS-CoV-2 infection by both neurologists and non-neurologists: An international inter-observer variability study.
    Tamborska AA; Wood GK; Westenberg E; Garcia-Azorin D; Webb G; Schiess N; Netravathi M; Baykan B; Dervaj R; Helbok R; Lant S; Özge A; Padovani A; Saylor D; Schmutzhard E; Easton A; Lilleker JB; Jackson T; Beghi E; Ellul MA; Frontera JA; Pollak T; Nicholson TR; Wood N; Thakur KT; Solomon T; Stark RJ; Winkler AS; Michael BD;
    J Neurol Sci; 2023 Jun; 449():120646. PubMed ID: 37100018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guillain-Barré Syndrome Associated with COVID-19 Vaccination.
    Finsterer J; Scorza FA; Scorza CA
    Emerg Infect Dis; 2022 May; 28(5):1079-1080. PubMed ID: 35447058
    [No Abstract]   [Full Text] [Related]  

  • 28. Acute-onset chronic inflammatory demyelinating polyneuropathy after COVID-19 infection and subsequent ChAdOx1 nCoV-19 vaccination.
    Suri V; Pandey S; Singh J; Jena A
    BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34607818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guillain-Barré Syndrome Variant Occurring after SARS-CoV-2 Vaccination.
    Allen CM; Ramsamy S; Tarr AW; Tighe PJ; Irving WL; Tanasescu R; Evans JR
    Ann Neurol; 2021 Aug; 90(2):315-318. PubMed ID: 34114269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 Vaccination and Neuroimmunological Disease: A Review.
    Willison AG; Pawlitzki M; Lunn MP; Willison HJ; Hartung HP; Meuth SG
    JAMA Neurol; 2024 Feb; 81(2):179-186. PubMed ID: 38227318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Letter to the Editor: Pre-Existing Neuropathy Favours SARS-CoV-2 Vaccination Associated Guillain-Barre Syndrome.
    Finsterer J
    J Korean Med Sci; 2022 Jul; 37(26):e217. PubMed ID: 35790211
    [No Abstract]   [Full Text] [Related]  

  • 32. The Impact of COVID-19 and Vaccine on the Human Nervous System.
    Chen F; Cao P; Liu H; Cai D
    Neuroendocrinology; 2022; 112(11):1046-1057. PubMed ID: 35316815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review of neurological side effects of COVID-19 vaccination.
    Hosseini R; Askari N
    Eur J Med Res; 2023 Feb; 28(1):102. PubMed ID: 36841774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What Are the Risks of Guillain-Barré Syndrome After SARS-CoV-2 Infection and COVID-19 Vaccination?
    Bourdette D; Silbermann E
    Neurology; 2023 Nov; 101(20):875-876. PubMed ID: 37852787
    [No Abstract]   [Full Text] [Related]  

  • 35. Neurological Immune-Related Adverse Events After COVID-19 Vaccination: A Systematic Review.
    Shafiq A; Salameh MA; Laswi I; Mohammed I; Mhaimeed O; Mhaimeed N; Mhaimeed N; Paul P; Mushannen M; Elshafeey A; Fares A; Holroyd S; Zakaria D
    J Clin Pharmacol; 2022 Mar; 62(3):291-303. PubMed ID: 34921562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spectrum of neurological complications following COVID-19 vaccination.
    Garg RK; Paliwal VK
    Neurol Sci; 2022 Jan; 43(1):3-40. PubMed ID: 34719776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute transverse myelitis after inactivated COVID-19 vaccine.
    Erdem NŞ; Demirci S; Özel T; Mamadova K; Karaali K; Çelik HT; Uslu FI; Özkaynak SS
    Ideggyogy Sz; 2021 Jul; 74(7-08):273-276. PubMed ID: 34370410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anaphylaxis is a rare reaction in COVID-19 vaccination.
    Bellomo RG; Gallenga CE; Caraffa A; Tetè G; Ronconi G; Conti P
    J Biol Regul Homeost Agents; 2021; 35(3):839-842. PubMed ID: 34105336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A review of the potential neurological adverse events of COVID-19 vaccines.
    Mohseni Afshar Z; Sharma A; Babazadeh A; Alizadeh-Khatir A; Sio TT; Taghizadeh Moghadam MA; Tavakolli Pirzaman A; Mojadad A; Hosseinzadeh R; Barary M; Ebrahimpour S
    Acta Neurol Belg; 2023 Feb; 123(1):9-44. PubMed ID: 36385246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variant Guillain-Barre Syndrome Following SARS-CoV-2 Vaccination: Case Report and Review of the Literature.
    Donaldson L; Margolin E
    Can J Neurol Sci; 2023 Jan; 50(1):138-140. PubMed ID: 35532270
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.